Highlights,ResMed's stock price dips below its 200-day moving average.,The company posted strong quarterly earnings, ...

Shares of ResMed Inc. RMD inched 0.56% higher to $233.88 Thursday, on what proved to be an all-around mixed trading session ...

Goldman Sachs has a buy rating and $36.20 price target on Woolworths' shares. Sign Up for Take Stock Investment news, stock ...

ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Shares of ResMed Inc. RMD slid 0.30% to $233.18 Friday, on what proved to be an all-around grim trading session for the stock ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Chip stocks advanced, led by Broadcom ( AVGO) after UBS analysts raised their price target for the stock, citing the ...

Check the time stamp on this data. Updated AI-Generated Signals for Resmed Inc. (RMD) available here: RMD.

During five years of share price growth, ResMed achieved compound earnings per share (EPS) growth of 21% per year. This EPS growth is higher than the 8% average annual increase in the share price.

Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea.

Shares of ResMed Inc. (NYSE:RMD – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $237.27, but opened at $230.21. ResMed shares last traded at $226 ...

Though Apple's expensive headset was been praised for its cutting-edge technology, the device is expensive and hasn't yet ...